Benitec Biopharma
BNTC
BNTC
55 hedge funds and large institutions have $325M invested in Benitec Biopharma in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 57 → 55 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
55
Holding in Top 10
2
Calls
–
Puts
$1K
Top Buyers
| 1 | +$3.18M | |
| 2 | +$2.43M | |
| 3 | +$1.15M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$804K |
| 5 |
AIC
AWM Investment Company
New York
|
+$631K |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$503K | |
| 3 | -$442K | |
| 4 |
Morgan Stanley
New York
|
-$255K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$207K |
